Dabigatran (Pradaxa)

Jules Comin, David F Kallmes

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Dabigatran (Pradaxa) is a member of the relatively new class of antithrombotic drugs known as direct thrombin inhibitors (DTIs). It may supplant warfarin (Coumadin) in a number of applications as it may produce a more predictable, potent, and immediate anticoagulant effect, with fewer significant side effects and interactions, and requires less monitoring.

Original languageEnglish (US)
Pages (from-to)426-428
Number of pages3
JournalAmerican Journal of Neuroradiology
Volume33
Issue number3
DOIs
StatePublished - Mar 2012

    Fingerprint

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this